Crinetics Pharmaceuticals (CRNX) EPS (Weighted Average and Diluted): 2020-2025
Historic EPS (Weighted Average and Diluted) for Crinetics Pharmaceuticals (CRNX) over the last 4 years, with Sep 2025 value amounting to -$1.38.
- Crinetics Pharmaceuticals' EPS (Weighted Average and Diluted) fell 43.75% to -$1.38 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.52, marking a year-over-year decrease of 21.83%. This contributed to the annual value of -$3.69 for FY2024, which is negligibly% changed negligibly from last year.
- Crinetics Pharmaceuticals' EPS (Weighted Average and Diluted) amounted to -$1.38 in Q3 2025, which was down 12.20% from -$1.23 recorded in Q2 2025.
- In the past 5 years, Crinetics Pharmaceuticals' EPS (Weighted Average and Diluted) registered a high of -$0.68 during Q4 2021, and its lowest value of -$1.38 during Q3 2025.
- For the 3-year period, Crinetics Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around -$1.00, with its median value being -$0.94 (2024).
- In the last 5 years, Crinetics Pharmaceuticals' EPS (Weighted Average and Diluted) rose by 5.01% in 2021 and then crashed by 43.75% in 2025.
- Crinetics Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.68 in 2021, then fell by 22.39% to -$0.83 in 2022, then declined by 6.02% to -$0.88 in 2023, then grew by 1.14% to -$0.87 in 2024, then plummeted by 43.75% to -$1.38 in 2025.
- Its last three reported values are -$1.38 in Q3 2025, -$1.23 for Q2 2025, and -$1.04 during Q1 2025.